- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2016
- Public Summary Document (PSD) November 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2016 PBAC Meeting - Word
Goserelin – November 2016
Goserelin: Implant, 3.6 mg, Implant 10.8 mg; Zoladex® Implant
Last updated
17 March 2017